Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial

Clinical and Experimental Allergy

Volumn 45, Issue 5, 2015, Pages 908-919

  Berthon, B S ^a   Gibson, P G ^a   Mcelduff, P ^b   Macdonald Wicks, L K ^c   Wood, L G ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Appetite; Asthma; Corticosteroids; Diet; Leptin

Indexed keywords

LEPTIN; PLACEBO; PREDNISOLONE; CORTICOSTEROID;

ADULT; APPETITE; ARTICLE; ASTHMA; BLOATING; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CONSTIPATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DECREASED APPETITE; DIARRHEA; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EOSINOPHIL; FEMALE; FLUID RETENTION; GASTROINTESTINAL REFLUX; HUMAN; IMPEDANCE; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MUSCLE WEAKNESS; NAUSEA; POLYDIPSIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SPIROMETRY; VISUAL ANALOG SCALE; VOMITING; AGED; AUSTRALIA; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; LEUKOCYTE COUNT; MIDDLE AGED; MORPHOMETRICS; ORAL DRUG ADMINISTRATION; QUESTIONNAIRE; YOUNG ADULT;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGED; APPETITE; ASTHMA; AUSTRALIA; BODY COMPOSITION; BODY WEIGHT; BODY WEIGHTS AND MEASURES; CROSS-OVER STUDIES; EOSINOPHILS; FEMALE; HUMANS; LEPTIN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84927713872     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12505     Document Type: Article

References (58)

1. Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 2007; 30:861-81.
2. Bateman ED, Hurd SS, Barnes PJ et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-78.
3. MIMS Online. Panafacort - full prescribing information. 2004. Available from: https://www.mimson.lline.com.au (Last accessed 3 May 2011).
4. Gamble J, Fitzsimons D, Lynes D, Heaney LG. Difficult asthma: people's perspectives on taking corticosteroid therapy. J Clin Nurs 2007; 16:59-67.
5. Berthon BS, MacDonald-Wicks LK, Wood LG. A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans. Nutr Res 2014; 34:179-90.
6. Australian Centre for Asthma Monitoring. Asthma in Australia 2011. AIHW Asthma Series no 4 Cat no ACM 22. Canberra, ACT: AIHW, 2011.
7. Curtis JR, Westfall AO, Allison J et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Care Res 2006; 55:420-6.
8. Wark PAB, Gibson PG. Asthma exacerbations · 3: pathogenesis. Thorax 2006; 61:909-15.
9. Bloomberg GR. The exacerbation component of impairment and risk in pediatric asthma. Curr Opin Allergy Clin Immunol 2010; 10:155-60.
10. Krishnan JA, Davis SQ, Naureckas ET, Gibson PG, Rowe BH. An umbrella review: corticosteroid therapy for adults with acute asthma. Am J Med 2009; 122:977-91.
11. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175:661-6.
12. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006; 27:495-503.
13. Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME. Body mass index and phenotype in subjects with mild to moderate persistent asthma. J Allergy Clin Immunol 2009; 123:1328-34.
14. Mosen DM, Schatz M, Magid DJ, Camargo CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122:507-11.
15. Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008; 121:1087-93.
16. Komakula S, Khatri S, Mermis J et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res 2007; 8:32-41.
17. Gibson CD, Carnell S, Ochner CN, Geliebter A. Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite. J Neuroendocrinol 2010; 22:833-46.
18. Aaron SD, Vandemheen KL, Hebert P et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348:2618-25.
19. Hankinson J, Odencrantz J, Fedan K. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-87.
20. Wood LG, Powell H, Gibson PG. Mannitol challenge for assessment of airway responsiveness, airway inflammation and inflammatory phenotype in asthma. Clin Exp Allergy 2009; 40:232-41.
21. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14:902-7.
22. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2012 (update). 2012. Available from: http://wwwginasthmaorg (Last accessed 30 July 2013).
23. White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG. Development and validation of the food-craving inventory. Obesity 2002; 10:107-14.
24. Cardelloa AV, Schutzb HG, Lesherc LL, Merrillc E. Development and testing of a labeled magnitude scale of perceived satiety. Appetite 2005; 44:1-13.
25. Baigelman W, Chodosh S, Pizzuto D, Cupples LA. Sputum and blood eosinophils during corticosteroid treatment of acute exacerbations of asthma. Am J Med 1983; 75:929-36.
26. Bafadhel M, McKenna S, Terry S et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med 2012; 186:48-55.
27. Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009; 180:817-22.
28. Wilson AM, Lipworth BJ. Short-term dose-response relationships for the relative systemic effects of oral prednisolone and inhaled fluticasone in asthmatic adults. Br J Clin Pharmacol 1999; 48:579-85.
29. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989;84(5 Part 1):688-700.
30. White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011; 342:d40.
31. Senn S. Cross-over trials in clinical research, 2nd edn. Chichester: John Wiley & Sons Ltd, 2002.
32. Wolthers T, Grofte T, Norrelund H et al. Differential effects of growth hormone and prednisolone on energy metabolism and leptin levels in humans. Metabolism 1998; 47:83-8.
33. Berneis K, Vosmeer S, Keller U. Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man. Eur J Endocrinol 1996; 135:663-5.
34. Jollin L, Rieth N, Thomasson R, Amiot V, Lasne F, Collomp K. Changes in adipokines but not in body composition after one week of prednisone intake in physically fit women. Endocrine 2013; 43:444-6.
35. Udden J, Bjorntorp P, Arner P, Barkeling B, Meurling L, Rossner S. Effects of glucocorticoids on leptin levels and eating behaviour in women. J Intern Med 2003; 253:225-31.
36. Rieth N, Jollin L, Le Panse B et al. Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men. Eur J Appl Physiol 2009; 105:309-13.
37. Kolaczynski JW, Goldstein BJ, Considine RV. Dexamethasone, OB gene, and leptin in humans; effect of exogenous hyperinsulinemia. J Clin Endocrinol Metab 1997; 82:3895-7.
38. Larsson H, Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996; 81:4428-32.
39. Chiodera P, Volpi R, Capretti L, Cataldo S, Speroni G, Coiro V. Effect of systemic oxytocin administration on dexamethasone-induced leptin secretion in normal and obese men. J Clin Endocrinol Metab 2000; 85:3683-6.
40. Dagogo-Jack S, Liu J, Askari H, Tykodi G, Umamaheswaran I. Impaired leptin response to glucocorticoid as a chronic complication of diabetes. J Diabetes Complicat 2000; 14:327-32.
41. Fardet L, Antuna-Puente B, Vatier C et al. Adipokine profile in glucocorticoid-treated patients: baseline plasma leptin level predicts occurrence of lipodystrophy. Clin Endocrinol (Oxf) 2013; 78:43-51.
42. Cimmino MA, Andraghetti G, Briatore L et al. Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica. Ann N Y Acad Sci 2010; 1193:160-3.
43. Patel JV, Cummings DE, Girod JP et al. Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment. J Negat Results Biomed 2006; 5:14.
44. Tataranni PA, Pratley R, Maffei M, Ravussin E. Acute and prolonged administration of glucocorticoids (methylprednisolone) does not affect plasma leptin concentration in humans. Int J Obes Relat Metab Disord 1997; 21:327-30.
45. Berthon BS, Macdonald-Wicks LK, Gibson PG, Wood LG. Investigation of the association between dietary intake, disease severity and airway inflammation in asthma. Respirology 2013; 18:447-54.
46. Laferrère B, Fried SK, Hough K, Campbell SA, Thornton J, Pi-Sunyer FX. Synergistic effects of feeding and dexamethasone on serum leptin levels. J Clin Endocrinol Metab 1998; 83:3742-5.
47. Miell JP, Englaro P, Blum WF. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res 1996; 28:704-7.
48. Brotman DJ, Girod JP, Garcia MJ et al. Effects of short-term glucocorticoids on cardiovascular biomarkers. J Clin Endocrinol Metab 2005; 90:3202-8.
49. van Schaik IN, Eftimov F, van Doorn PA et al. Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9:245-53.
50. Tataranni PA, Larson DE, Snitker S, Young JB, Flatt JP, Ravussin E. Effects of glucocorticoids on energy metabolism and food intake in humans. Am J Physiol 1996; 271(2 Pt 1):E317-25.
51. Askari H, Liu J, Dagogo-Jack S. Energy adaptation to glucocorticoid-induced hyperleptinemia in human beings. Metabolism 2005; 54:876-80.
52. Japanese Society of Hypertension. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Hypertens Res 2006; 29(Suppl.):S1-102.
53. Horber FF, Scheidegger JR, Grunig BE, Frey FJ. Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest 1985; 15:302-7.
54. Nishimura Y, Nakata H, Shirotani T, Kotani Y, Maeda H, Yokoyama M. Effects of steroids on bone mineral content in women with bronchial asthma. Allergol Int 1998; 47:117-22.
55. Short KR, Nygren J, Bigelow ML, Nair KS. Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function. J Clin Endocrinol Metab 2004; 89:6198-207.
56. Smith A, Krishnan JA, Bilderback A, Riekert KA, Rand CS, Bartlett SJ. Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest 2006; 130:1034-8.
57. Krishnan JA, Riekert KA, McCoy JV et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004; 170:1281-5.
58. Robinson DS, Campbell DA, Durham SR et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22:478-83.